drugset / Trial / NCT01042392
Efficacy of Aliskiren Compared to Ramipril in the Treatment of Moderate Systolic Hypertensive Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
This prospective multicenter, double blind study will evaluate the efficacy and safety of aliskiren versus ramipril in patients with moderate systolic essential hypertension.
Timeline
- Start
- 2009-11
- Primary completion
- 2011-01
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Aliskiren | Small molecule | 150 mg | — |
| Subject | Aliskiren | Small molecule | 300 mg | — |
| Comparator | Ramipril | Small molecule | 5 mg | — |
| Comparator | Ramipril | Small molecule | 10 mg | — |